All AbMole products are for research use only, cannot be used for human consumption.
BN-104 (BNM-1192) is a novel, potent and highly selective, oral menin inhibitor. BN-104 (BNM-1192) can inhibit the Menin-MLL interaction. BN-104 (BNM-1192) can be used in cancer research, such as acute myeloid leukemia.
| Molecular Weight | 570.66 |
| Formula | C31H35FN8O2 |
| CAS Number | 2938995-50-5 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Related Epigenetic Reader Domain Products |
|---|
| Phoenixin-20
Phoenixin-20 (PNX-20) is a bioactive peptide with hormone-like actions in vertebrates, and can stimulates hypothalamo-pituitary-gonadal hormones and regulate reproductive processes in mammals. |
| Menin-MLL inhibitor 31
Menin-MLL inhibitor 31 is a potent inhibitor of the menin MLL interaction with an IC50 value of 4.6 nM. |
| OPN-2853
OPN-2853 is a bromodomain protein-4 (BRD4) inhibitor that can be used in studies related to hematologic and lymphatic disorders. |
| HDAC/JAK/BRD4-IN-1
HDAC/JAK/BRD4-IN-1 is a potent HDAC/JAK/BRD4 triple inhibitor. |
| VYN-201
VYN-201 is a novel pan-BET inhibitor for studies related to idiopathic pulmonary fibrosis. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
